Maj J, Melzacka M, Rogóz Z, Skuza G, Sowińska H
Pol J Pharmacol Pharm. 1982 Nov-Dec;34(5-6):323-31.
Proadifen (SKF 524 A) inhibited the following effects of imipramine (IMI), without affecting those of desipramine (DMI) in mice: antagonism towards reserpine-induced hypothermia, ptosis and sedation, antagonism to apomorphine hypothermia and insignificant shortening of the immobility time in the behavioral despair test. Cerebral levels of DMI were very low after administration of IMI; pretreatment with proadifen did not affect the already low levels of DMI but significantly elevated these of IMI. This may indicate that some other than DMI metabolites (e.g., 2-hydroxy-derivatives) may be of importance for the action of IMI in mice in the tests employed in this study.
丙胺苯丙酮(SKF 524 A)可抑制丙咪嗪(IMI)在小鼠体内产生的以下效应,而不影响去甲丙咪嗪(DMI)的效应:对利血平诱导的体温过低、眼睑下垂和镇静的拮抗作用,对阿扑吗啡诱导的体温过低的拮抗作用,以及在行为绝望试验中对不动时间的轻微缩短。给予IMI后,脑内DMI水平非常低;用丙胺苯丙酮预处理并不影响本已很低的DMI水平,但显著提高了IMI的脑内水平。这可能表明,在本研究采用的试验中,除DMI代谢产物(如2-羟基衍生物)之外的其他物质可能对IMI在小鼠体内的作用具有重要意义。